Statistics for USANA Health Sciences (id:9607 USNA)

Valuation metrics

Market cap

768.86M

Enterprise value

403.97M

Trailing P/E (ttm)

14.25

Forward P/E

16.27

PEG ratio

16.27

Price/Sales (ttm)

0.89

Price/Book (mrq)

1.44

Enterprise Value/Revenue

0.47

Enterprise Value/EBITDA

4.22

Overview

Shares outstanding

19.06M

Float

9.96M

Shares short

516.56K

% Held by insiders

0.42%

% Held by institutions

0.58%

Average volume (10 days)

87.52K

Average volume (90 days)

Price summary

52-Week low

34.15

52-Week high

54.81

52-Week change

-16.67%

Beta

0.89

50-Day moving average

37.63

200-Day moving average

43.50

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 23th, 2016

Financials

Fiscal year

Fiscal year ends

December 30th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

6.30%

Operating margin

7.79%

Operational effectiveness

Return on assets

8.09%

Return on equity

10.83%

Income statement

Revenue (ttm)

45.08

Revenue per share (ttm)

45.08

Quarterly revenue growth (yoy)

-0.06

Gross profit (ttm)

744.32M

EBITDA

114.05M

Net income to common (ttm)

54.34M

Diluted EPS (ttm)

2.83

Quarterly earnings growth (yoy)

-6.50%

Balance sheet

Total cash (mrq)

364.89M

Total cash per share (mrq)

19.14

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

393.10%

Book value per share (mrq)

27.98

Cash flow

Cash flow statement

81.23M

Levered free cash flow (LFCF)

71.15M